Literature DB >> 27591490

Refinements in Sarcoma Classification in the Current 2013 World Health Organization Classification of Tumours of Soft Tissue and Bone.

Vickie Y Jo1, Leona A Doyle2.   

Abstract

The fourth edition of the World Health Organization (WHO) Classification of Tumours of Soft Tissue and Bone was published in February 2013. The 2013 WHO volume provides an updated classification scheme and reproducible diagnostic criteria, which are based on recent clinicopathologic studies and genetic and molecular data that facilitated refined definition of established tumor types, recognition of novel entities, and the development of novel diagnostic markers. This article reviews updates and changes in the classification of bone and soft tissue tumors from the 2002 volume.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone; Classification; Histology; Sarcoma; Soft tissue; Tumor; World Health Organization

Mesh:

Year:  2016        PMID: 27591490     DOI: 10.1016/j.soc.2016.05.001

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  37 in total

1.  Microvesicles derived from human bone marrow mesenchymal stem cells promote U2OS cell growth under hypoxia: the role of PI3K/AKT and HIF-1α.

Authors:  Shanshan Lin; Bo Zhu; Guozhi Huang; Qing Zeng; Chuhuai Wang
Journal:  Hum Cell       Date:  2018-11-30       Impact factor: 4.174

Review 2.  Imaging following surgery for primary appendicular bone tumours.

Authors:  Imran Khan; Craig Gerrand; Asif Saifuddin
Journal:  Skeletal Radiol       Date:  2021-01-22       Impact factor: 2.199

Review 3.  Recent translational research into targeted therapy for liposarcoma.

Authors:  Rashi Bharat Patel; Ting Li; Zhichao Liao; Jivani Aakash Jaldeepbhai; H A Pavanika N V Perera; Sujani Kaushalya Muthukuda; Dholiya Hardeep Dhirubhai; Vaibhav Singh; Xiaoling Du; Jilong Yang
Journal:  Stem Cell Investig       Date:  2017-03-15

Review 4.  Extremity Soft Tissue Sarcoma: Role of Local Control.

Authors:  Elyse J Brinkmann; Safia K Ahmed; Matthew T Houdek
Journal:  Curr Treat Options Oncol       Date:  2020-02-05

Review 5.  Application of metabolomics in sarcoma: From biomarkers to therapeutic targets.

Authors:  Li Min; Edwin Choy; Chongqi Tu; Francis Hornicek; Zhenfeng Duan
Journal:  Crit Rev Oncol Hematol       Date:  2017-05-13       Impact factor: 6.312

Review 6.  Neoadjuvant chemotherapy in soft tissue sarcomas: latest evidence and clinical implications.

Authors:  Sandro Pasquali; Alessandro Gronchi
Journal:  Ther Adv Med Oncol       Date:  2017-04-16       Impact factor: 8.168

7.  Targeting specificity protein 1 transcription factor and survivin using tolfenamic acid for inhibiting Ewing sarcoma cell growth.

Authors:  Sagar Shelake; Umesh T Sankpal; W Paul Bowman; Matthew Wise; Anish Ray; Riyaz Basha
Journal:  Invest New Drugs       Date:  2016-12-26       Impact factor: 3.850

8.  Venous Thromboembolism in Patients with Sarcoma: A Retrospective Study.

Authors:  Thierry Alcindor; Ali Al-Fakeeh; Krista Goulding; Susan Solymoss; Nathalie Ste-Marie; Robert Turcotte
Journal:  Oncologist       Date:  2018-09-26

9.  Magnetic resonance imaging follow-up of chondroid tumors: regression vs. progression.

Authors:  Bo Mi Chung; Sung Hwan Hong; Hye Jin Yoo; Ja-Young Choi; Hee-Dong Chae; Dong Hyun Kim
Journal:  Skeletal Radiol       Date:  2017-12-03       Impact factor: 2.199

10.  Well-Differentiated Liposarcoma Localized to the Thyroid Gland.

Authors:  Amruth R Palla; Craig Allen Bollig; Jeffrey Brian Jorgensen
Journal:  Eur Thyroid J       Date:  2018-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.